Shareholder Relations and Voting

International Biotechnology Trust plc recognises that maintaining good relationships with and actively engaging with both its institutional and retail investors is vital to its long term prospects.
International Biotechnology Trust is committed to forging excellent relationships with current and potential investors.


Dialogue between investors and the Board is encouraged, via the Annual General Meeting or through the broker and/or the Investment Manager. The Investment Manager has recently engaged an Investor Relations Director, Lucy Costa Duarte, whose role is to encourage stronger relationships with current and potential investors.


The Annual General Meeting is usually held in December, and the Annual Report is sent to investors at least 20 days beforehand.


Details of proxy votes received in respect of each resolution are made available to shareholders at the meeting and are published on this website following the meeting.



  • You are seeing this because you are accessing IBT’s website for the first time.


  • The information on this website may only be suitable for certain types of investors and is not intended to be used or relied upon by any other person.


  • An investment with IBT may contain significant risks and is intended only for sophisticated investors who meet certain eligibility criteria.


  • The material on this website is intended to be viewed only by persons resident in the EEA.


  • The information on this website is not an offer to sell or a solicitation of an offer and does not constitute investment advice.


  • No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information or opinions contained therein.


  • The information on this website may constitute financial promotion for the purposes of the Financial Services and Markets Act 2000 (“FSMA”).